We cordially invite you to take part in the CancerCoreEurope Conference on Lymphoma held in Heidelberg 22nd of January 2016.
The optimal treatment of cancer remains one of the major medical challenges globally. To collectively carry out joint translational and clinical research in cancer treatment and care, Gustave Roussy Cancer Campus Grand Paris (Villejuif, France), Cambridge Cancer Centre (Cambridge, England), Karolinska Institutet – KI (Stockholm, Sweden), Netherlands Cancer Institute – NKI (Amsterdam, The Netherlands), Vall d’Hebron Institute of Oncology – VHIO (Barcelona, Spain) and the German Cancer Research Center – DKFZ and its National Center for Tumor Diseases – NCT (Heidelberg, Germany) have jointly created Cancer Core Europe. Given the excellent track records of the six participants, Cancer Core Europe will be able to support the full spectrum of research required to address the cancer research – cancer care continuum. Cancer Core Europe also constitutes a unique environment for the training of up-and-coming talents in innovative translational and clinical oncology.
In the light of exciting new molecular insight in lymphoma biology which rapidly transforms current treatment approaches, the one day meeting will summarize our current understanding of pathogenesis, sum up current standard treatments and discuss future developments in indolent lymphoma, CLL, aggressive B- and T cell lymphoma.
We look forward to welcoming you in Heidelberg.